Analytical Data
-
Gene name
LCN9
- Application
-
Alternative Names
MUP-like lipocalin; Epididymal-specific lipocalin-9
-
Species
Rat
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
B3EY87
-
Expression Region
Arg33~Leu163
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LCN9, or lipocalin 9, is a member of the lipocalin superfamily known for its role in transporting small hydrophobic molecules. Research on LCN9 has gained significant interest due to its potential implications in various physiological processes and its association with certain diseases. It is primarily expressed in the reproductive system, where it is believed to play a role in sperm maturation and functionality, suggesting a crucial involvement in male fertility. Additionally, studies have indicated its possible link to metabolic disorders and inflammatory responses, making it a candidate for further investigation in understanding these complex pathways. The recombinant protein of LCN9 offers a valuable tool for elucidating its structure-function relationships, allowing researchers to explore its binding properties and therapeutic potentials. By producing LCN9 in a recombinant system, scientists can obtain large quantities of the protein necessary for detailed biochemical and biophysical analyses. This research not only enhances our understanding of LCN9’s biological roles but may also pave the way for innovative strategies in treating related reproductive and metabolic disorders. Moreover, the exploration of LCN9’s interactions with various ligands and its mechanism of action could lead to significant advancements in drug development. Therefore, the ongoing studies surrounding LCN9 recombinant proteins are critical for unraveling the complexities of its functions and therapeutic applications, contributing to the broader fields of reproductive health and metabolic disease management.
